FDA Nod For Novartis Drug To Avert Organ Failure In Liver TransplantRTT NewsSwiss drug maker Novartis AG (NVS: Quote), said Friday the U.S. Food and Drug Administration has approved Zortress as the first immunosuppressant in a decade to prevent organ r…
FDA Nod For Novartis Drug To Avert Organ Failure In Liver Transplant – NASDAQ
FDA Nod For Novartis Drug To Avert Organ Failure In Liver TransplantNASDAQThe approval also means that Zortress (everolimus) is the first mammalian target of rapamycin (mTOR) inhibitor to prevent organ rejection in adult liver transplant patients in th…
US FDA okays Novartis drug to prevent liver transplant rejection – Reuters
US FDA okays Novartis drug to prevent liver transplant rejectionReutersThe immune system drug, also known as everolimus, is already approved by the Food and Drug Administration for preventing organ rejection for kidney transplant patients. Regulators i…
Bone marrow transplantation in SCB soon – Times of India
|
Bone marrow transplantation in SCB soon
Times of India CUTTACK: The SCB Medical College and Hospital is all set to start the state’s first bone marrow transplantation (BMT) unit in June. Preparations for it are on full swing in the haematology department. The groundwork for establishing the unit, which … |
California's Prop 65 and Public Health Concerns over Methyl Isocyanate – Environmental Expert (press release)
|
California’s Prop 65 and Public Health Concerns over Methyl Isocyanate
Environmental Expert (press release) In Bhopal, India, accidental acute inhalation exposure to methyl isocyanate resulted in the deaths of about 3,800 people and adverse health effects in greater than 170,000 survivors.” “Occupational exposure to methyl isocyanate may occur with … The … |
FDA Oks Novartis's Zortress For Liver Transplantation – Quick Facts – NASDAQ
|
FDA Oks Novartis’s Zortress For Liver Transplantation – Quick Facts
NASDAQ According to the company, Zortress is the first mammalian target of rapamycin (mTOR) inhibitor approved for use following liver transplantation. It is also … In most EU member countries, Certican is also approved in kidney and heart transplantation … |
Toddler gets non-invasive brain surgery with help of "medical crazy glue" – CBS News
|
Toddler gets non-invasive brain surgery with help of “medical crazy glue”
CBS News The abnormal vessels weaken over time and may burst, causing bleeding in the brain. Death risk climbs 10 to 15 percent with each brain bleed and risk for permanent brain damage increases 20 to 30 percent with each bleed. Less than 1 percent of people … |
FDA Oks Novartis's Zortress For Liver Transplantation – Quick Facts – RTT News
|
FDA Oks Novartis’s Zortress For Liver Transplantation – Quick Facts
RTT News According to the company, Zortress is the first mammalian target of rapamycin (mTOR) inhibitor approved for use following liver transplantation. It is also … In most EU member countries, Certican is also approved in kidney and heart transplantation … |
Safe Haven: A typical Nicholas Sparks love story – Mid Columbia Tri City Herald
 Mid Columbia Tri City Herald |
Safe Haven: A typical Nicholas Sparks love story
Mid Columbia Tri City Herald Those not loving love stories find films based on Nicholas Sparks novels as close as they’ll ever get to brain death until the real thing comes at the end of their lives. The latest of Sparks’ heavy-handed, formula chick flicks is Safe Haven, and it’s … |
Organ transplant: Doctors cheer move to scrap NOC – Times of India
|
Organ transplant: Doctors cheer move to scrap NOC
Times of India His doctor, Bharat Shah, who had moved the Bombay high court against the need for an NOC for interstate transplants when the donor and recipient are related, is ecstatic. “The problem is that this NOC was interpreted and followed differently in … |